GvW Graf von Westphalen advises Venn Life Sciences on the acquisition of shares in CRM clinical trials
With GvW Graf von Westphalen’s support, Venn Life Sciences Holdings plc has acquired pharmaceutical research company CRM clinical trials GmbH by way of an asset deal.
English company Venn Life Sciences Holdings plc is listed at the London Stock Exchange (AIM) and has mainly been dealing with the implementation of pharmaceutical studies for more than 24 years. Up to now, the contract research organization which is acting throughout Europe has not yet been active in Germany.
Through the acquisition of North Rhine Westphalia-based CRM clinical trials GmbH, Venn Life Sciences intends to establish itself in the German market. CRM clinical trials is a mid-size pharmaceutical consulting company with longstanding experience in the planning and implementation of clinical investigations. After the acquisition, Venn Life Sciences will have operations in more than seven European countries.
Venn Life Sciences was advised on this transaction by Frankfurt-based partner Eric Messenzehl and his associate Benjamin Schwarzfischer (both commercial and corporate law, Frankfurt). They were supported by Karsten Kujath (labour law, Frankfurt).
News
Federal Administrative Court: Fehmarn Belt Fixed Link may be built
The Federal Administrative Court has dismissed all six pending appeals against the planning decision on the Fehmarn Belt Fixed Link. Construction of the tunnel may therefore now also begin in Germany. GvW advised the State of Schleswig-Holstein and was represented by a Hamburg team consisting of Dr Ronald Steiling (lead), Corinna Lindau, Dr Dietrich Drömann, Prof. Dr Christian Winterhoff, Dr Andreas Wolowski, Saskia Soravia, Dr Stefanie Ramsauer, Dr Annika Bleier, Felix Kazimierski and Niclas Langhans. (BVerwG 9 A 6.19, 9 A 7.19, 9 A 9.19, 9 A 10.19, 9 A 11.19, 9 A 12.19 and 9 A 13.19).
H4 Hotel Mönchengladbach at BORUSSIA-PARK: the place for that Bundesliga feeling
Football is king at H-Hotel Group’s new H4 Hotel in Mönchengladbach. Its location right next to the stadium and the theme rooms depicting the history of the Borussia Dortmund football club make this new hotel unique and a must for any football enthusiast. Our lawyers had the pleasure of advising H-Hotels Group on the creation of its first football-themed hotel and took the chance to visit this amazing place shortly after its opening.
Transport System Bögl: new local public passenger transport system a big success in China
The Max Bögl group of companies has developed a new local public passenger transport system. The system called “Transport System Bögl” (TSB) uses magnetic levitation, or “maglev” technology and provides a clean and cost-efficient means of transport for better mobility in inner city areas. The technology is becoming increasingly popular also in other countries: Max Bögl’s most recent export order was the sale of its TSB to China. The company’s plans include building a 3.5 km test track in Chengdu and extensive marketing activities to promote the technology in China – all through a sales partnership with a Chinese company.
You don't want to miss any more of the latest legal developments? And be invited to our events? Then register here.